At Minutia we are working towards a
transplant of insulin producing cells combined with nanosensors for diabetes.

We believe our ability to create more robust and controlled insulin producing cell transplants that can be monitored in vivo over time will revolutionize the current clinical landscape for diabetes and cell replacement therapy.

Press Releases

May 22, 2023

Minutia receives award from JDRF to further develop real-time monitoring platform for cell therapies

Oct 28, 2022

At Minutia, Katy Digovich is tackling diabetes cell by cell

Aug 1, 2022

Minutia receives $1,198,550 grant from California Institute for Regenerative Medicine

Sep 15, 2021

Minutia receives $300,000 grant from The National Institutes of Health

At Minutia we are working towards a transplant of insulin producing cells combined with nanosensors for diabetes.

Contact Us

General

Media

Investors

Careers

Find Us

At Minutia we are working towards a
transplant of insulin producing cells combined with nanosensors for diabetes.